0.6598
price up icon4.73%   0.0298
after-market 시간 외 거래: .62 -0.0398 -6.03%
loading

Vincerx Pharma Inc 주식(VINC)의 최신 뉴스

pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 28, 2025

Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 25, 2025

Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView

Mar 25, 2025
pulisher
Mar 19, 2025

Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register

Mar 19, 2025
pulisher
Mar 19, 2025

Vincerx Pharma plans reverse merger with QumulusAI By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

VINC stock touches 52-week low at $0.73 amid sharp annual decline - Investing.com UK

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI -March 18, 2025 at 09:40 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma plans reverse merger with QumulusAI - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma's $300M AI Transformation: QumulusAI Merger Creates New Computing Powerhouse - StockTitan

Mar 18, 2025
pulisher
Mar 03, 2025

Vincerx Pharma Plunges After Scrapping Reverse Merger With Oqory And Vivaso - Nasdaq

Mar 03, 2025
pulisher
Mar 02, 2025

Vincerx Pharma terminates reverse merger term sheet and evaluates strategic alternatives - MSN

Mar 02, 2025
pulisher
Feb 28, 2025

Vincerx Pharma Terminates Reverse Merger Deal With Oqory - MarketWatch

Feb 28, 2025
pulisher
Feb 28, 2025

Vincerx Pharma Explores Strategic Alternatives Post Merger Termination - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Vincerx Pharma Announces Termination Of Reverse Merger Term Sheet -February 28, 2025 at 04:12 pm EST - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Vincerx Pharma announces termination of reverse merger term sheet - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - The Manila Times

Feb 28, 2025
pulisher
Feb 28, 2025

Vincerx Pharma, Inc. Terminates Reverse Merger Agreement and Will Explore Strategic Alternatives - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Is Vincerx Pharma Running Out of Options? Merger Deal Collapses as Cash Dwindles - StockTitan

Feb 28, 2025
pulisher
Feb 28, 2025

Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update - Defense World

Feb 28, 2025
pulisher
Feb 24, 2025

VINC stock touches 52-week low at $1.17 amid market challenges - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

VINC stock touches 52-week low at $1.17 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 18, 2025

Vincerx Pharma Regains Compliance With Nasdaq Listing Rule 5550(A)(2) -February 18, 2025 at 05:27 pm EST - Marketscreener.com

Feb 18, 2025
pulisher
Feb 16, 2025

Vincerx Pharma announces reverse stock split; shares drop - MSN

Feb 16, 2025
pulisher
Feb 13, 2025

VINC stock touches 52-week low at $1.3 amid market challenges - Investing.com Australia

Feb 13, 2025
pulisher
Feb 02, 2025

Vincerx Pharma, Inc. (NASDAQ:VINC) Sees Large Increase in Short Interest - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Rises By 1,022.5% - MarketBeat

Jan 31, 2025
pulisher
Jan 29, 2025

VINC stock touches 52-week low at $1.62 amid market challenges - Investing.com Canada

Jan 29, 2025
pulisher
Jan 29, 2025

Vincerx Pharma, Oqory highlight Phase 1a/1b data for OQY-3258 - TipRanks

Jan 29, 2025
pulisher
Jan 29, 2025

Vincerx Pharma and Oqory reveal merger and cancer drug data - Investing.com

Jan 29, 2025
pulisher
Jan 29, 2025

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258 - GlobeNewswire

Jan 29, 2025
pulisher
Jan 29, 2025

Vincerx Pharma and Oqory reveal merger and cancer drug data By Investing.com - Investing.com UK

Jan 29, 2025
pulisher
Jan 29, 2025

Revolutionary Cancer Treatment Achieves Unprecedented 80% Success Rate in Clinical Trial - StockTitan

Jan 29, 2025
pulisher
Jan 28, 2025

Stock market news: Vincerx Pharma plunged by 95.86% while MiNK Therapeutics was down by 94.26% during mid day trading - Business Upturn

Jan 28, 2025
pulisher
Jan 28, 2025

Vincerx Pharma enters at-the-market equity offering deal - MSN

Jan 28, 2025
pulisher
Jan 28, 2025

Stock market today: Vincerx Pharma declined by 95.75% whereas Revelation Biosciences - Business Upturn

Jan 28, 2025
pulisher
Jan 27, 2025

Vincerx Pharma (NASDAQ:VINC) Stock Quotes, Forecast and News Summary - Benzinga

Jan 27, 2025
pulisher
Jan 27, 2025

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 27, 2025
pulisher
Jan 26, 2025

Vincerx Pharma files for $100M mixed securities shelf - MSN

Jan 26, 2025
pulisher
Jan 26, 2025

Vincerx Pharma (NASDAQ:VINC) Implements 1-for-20 Reverse Stock Split - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Palo Alto's Vincerx Pharma plans reverse stock split amid merger plans - The Business Journals

Jan 24, 2025
pulisher
Jan 24, 2025

Vincerx Pharma (VINC) Stock Price, News & Analysis - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Vincerx Pharma Inc. Announces Merger with Oqory - TipRanks

Jan 23, 2025
pulisher
Jan 23, 2025

Vincerx Pharma, Inc. Announces Reverse Stock Split - The Manila Times

Jan 23, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
자본화:     |  볼륨(24시간):